DR. BINSAH SUSAN GEORGE MD
Prescription History 1477818607
Internal Medicine - Hematology & Oncology in Houston, TX
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. BINSAH SUSAN GEORGE MD, an active Hematology & Oncology specialist practicing in Houston, TX. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 25 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydroxyurea, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Claims | 30-Day Fills | Days Supply | Cost / Claim | Utilization vs TX Avg |
|---|---|---|---|---|---|
| Hydroxyurea | 14 | 22.9 | 606 | $46.29 | ▼ Below Avg. |
Utilization: claims vs the average TX prescriber Averages are among TX prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the TX average Gross Part D cost per claim; not the patient's out-of-pocket price. 22.9 30-Day Fills 606 Days Supply About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. | |||||
| JakafiRuxolitinib Phosphate | 11 | 11.0 | 330 | $20,071.35 | ▼ Below Avg. |
Utilization: claims vs the average TX prescriber Averages are among TX prescribers of this medication. Utilization reflects practice size as well as clinical preference. Cost per claim: this provider vs the TX average Gross Part D cost per claim; not the patient's out-of-pocket price. 11.0 30-Day Fills 330 Days Supply About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). | |||||
About this data. The prescription history for DR. BINSAH SUSAN GEORGE MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Houston, TX practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among TX prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
